PR90451

CONSHOHOCKEN, Pa., July 7, 2021 /PRNewswire=KYODO JBN/--

--Appoints Experienced Technology Executives to lead Product and Marketing

Suvoda LLC, an innovator in clinical trial software, today announced the

expansion of its leadership team with the appointments of E.K. Koh to the

position of Chief Product Officer and Elena Filimonova to the position of Chief

Marketing Officer. Filimonova and Koh come to Suvoda with extensive backgrounds

in B2B technology and years of experience building and scaling customer-centric

organizations.

Logo - https://mma.prnewswire.com/media/1039295/Suvoda_Logo.jpg

For the past eight years, fast market adoption has driven Suvoda's rapid growth

and established the company as a leader in the clinical trial technology space.

Fueled by the recent investment from LLR Partners, Suvoda is scaling its

organization to support the growth while remaining laser-focused on expanding

its product functionality and upholding the superior level of customer support

for which the company is known.

As the industry shifts towards patient-centricity and trial virtualization, and

as trials themselves become more complex, Koh and his team will focus on

creating scalable solutions that provide greater efficiency in patient and

supply chain management to help clinical trial sponsors get new therapies to

patients faster.

Koh is an experienced product executive with a track record of scaling product

organizations, as well as defining and executing disruptive solutions with

strong product-market fit. He has an extensive background in product management

and development with companies like Experian, LiveRamp and Optymyze, among

others.

"I am personally motivated by Suvoda's mission to improve the lives of

patients," said Koh. "Clinical trials are ripe for product disruption, and I'm

excited to contribute to a company that combines transformative innovation with

an unparalleled focus on improving study execution."

As Chief Marketing Officer, Filimonova will drive worldwide brand and

go-to-market strategy with targeted marketing initiatives to support Suvoda's

business and growth goals.

"Suvoda is an exceptional company centered around a great team, innovative

products, and an outstanding level of customer service. I am honored to be part

of it. I am committed to further growing Suvoda's presence and elevating the

company's voice as an innovator in the clinical trial space by highlighting its

unique capabilities and expertise."

Filimonova has spent most of her career in B2B technology marketing. Her

experience and strategic focus have helped both start-ups and established

companies gain market recognition, drive growth, and bring new products to

market. Prior to joining Suvoda, Filimonova held marketing leadership positions

at Radianz, a Reuters-owned company, Knovel, Elsevier, and CGS.

"E.K. and Elena's comprehensive expertise and creative mindset will help us

support our deep focus on solving our customers' pain points. Both of their

positions will be instrumental in driving and executing Suvoda's overall

strategic initiatives and will play a key role as we continue our worldwide

growth," said Jagath Wanninayake, President and CEO of the company. "I am

particularly excited that both E.K. and Elena fit so well with our culture of

making a meaningful contribution in accelerating the clinical trial process."

SOURCE:  Suvoda LLC

CONTACT: Amy Szwajkowski

         +1-610-572-2920 Ext. 3368

         aszwajkowski@suvoda.com